Sarah Goldstein, MD, FACC
Assistant Professor
Research & Publications
Biography
News
Selected Publications
- Rheumatoid arthritis and peripartum cardiovascular complications: focusing on non-traditional cardiovascular risk factors to improve maternal outcomesGoldstein S, Lindley K. Rheumatoid arthritis and peripartum cardiovascular complications: focusing on non-traditional cardiovascular risk factors to improve maternal outcomes. European Heart Journal 2024, 45: 1537-1539. PMID: 38713839, DOI: 10.1093/eurheartj/ehae164.
- Complex Congenital Heart Disease in the AdultGoldstein S, Krasuski R. Complex Congenital Heart Disease in the Adult. Annual Review Of Medicine 2024, 75: 493-512. PMID: 38285514, DOI: 10.1146/annurev-med-050922-052324.
- 426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart diseaseDenoble A, Federspiel J, Goldstein S, Culhane J, Dysart K. 426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease. American Journal Of Obstetrics And Gynecology 2024, 230: s235-s236. DOI: 10.1016/j.ajog.2023.11.452.
- Maternal and Pregnancy Outcomes Following Heart Transplantation in the United StatesCraig A, Campbell A, Snow S, Spates T, Goldstein S, Denoble A, Meng M, Schroder J, Flores K, Agarwal R, Ward C, Federspiel J. Maternal and Pregnancy Outcomes Following Heart Transplantation in the United States. JACC Heart Failure 2023, 11: 1666-1674. PMID: 37804312, PMCID: PMC10841668, DOI: 10.1016/j.jchf.2023.08.018.
- Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic CardiomyopathyGoldstein S, Kennedy K, Friedman D, Al‐Khatib S, Wang A. Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy. Journal Of The American Heart Association 2023, 12: e029293. PMID: 37586066, PMCID: PMC10492935, DOI: 10.1161/jaha.122.029293.
- Antihypertensives in PregnancyDenoble A, Goldstein S, Pettker C. Antihypertensives in Pregnancy. Obstetrics And Gynecology Clinics Of North America 2023, 50: 39-78. PMID: 36822710, DOI: 10.1016/j.ogc.2022.10.008.
- Prospective Observational Study of N-terminal Pro–Brain Natriuretic Peptide Levels in Obese and Nonobese Women during PregnancyDenoble A, Moyett J, Goldstein S, Ward CC, Truong T, Erkanli A, James A, Grotegut C. Prospective Observational Study of N-terminal Pro–Brain Natriuretic Peptide Levels in Obese and Nonobese Women during Pregnancy. American Journal Of Perinatology 2022, 40: 467-474. PMID: 35973801, PMCID: PMC10168705, DOI: 10.1055/a-1925-1532.
- Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery HospitalizationsDenoble A, Goldstein S, Wein L, Grotegut C, Federspiel J. Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery Hospitalizations. JACC Advances 2022, 1: 100157. PMID: 36684662, PMCID: PMC9851052, DOI: 10.1016/j.jacadv.2022.100157.
- Abstract 13443: Clinical Outcomes Following Primary Prevention Implantable Cardioverter Defibrillator (ICD) Implantation Among Older Patients With Hypertrophic Cardiomyopathy (HCM)Goldstein S, kennedy K, Friedman D, Al-Khatib S, Wang A. Abstract 13443: Clinical Outcomes Following Primary Prevention Implantable Cardioverter Defibrillator (ICD) Implantation Among Older Patients With Hypertrophic Cardiomyopathy (HCM). Circulation 2022, 146: a13443-a13443. DOI: 10.1161/circ.146.suppl_1.13443.
- Abstract 13435: Utilization of Primary Prevention Implantable Cardioverter Defibrillator (ICD) Among Older Patients With Hypertrophic Cardiomyopathy (HCM): A Real World AnalysisGoldstein S, kennedy K, Friedman D, Al-Khatib S, Wang A. Abstract 13435: Utilization of Primary Prevention Implantable Cardioverter Defibrillator (ICD) Among Older Patients With Hypertrophic Cardiomyopathy (HCM): A Real World Analysis. Circulation 2022, 146: a13435-a13435. DOI: 10.1161/circ.146.suppl_1.13435.
- Hypertensive Disorders of Pregnancy and Heart Failure Risk.Goldstein SA, Pagidipati NJ. Hypertensive Disorders of Pregnancy and Heart Failure Risk. Current Hypertension Reports 2022, 24: 205-213. PMID: 35347569, DOI: 10.1007/s11906-022-01189-2.
- Risk Factors and Outcomes Associated With Hypertensive Disorders of Pregnancy in Maternal Congenital Heart DiseaseGoldstein S, Savu A, Islam S, Ward C, Krasuski R, Grotegut C, Newby L, Hornberger L, Windram J, Kaul P. Risk Factors and Outcomes Associated With Hypertensive Disorders of Pregnancy in Maternal Congenital Heart Disease. JACC Advances 2022, 1: 100036. PMID: 38939317, PMCID: PMC11198567, DOI: 10.1016/j.jacadv.2022.100036.
- Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular riskDenoble AE, Goldstein SA, Wein LE, Grotegut CA, Federspiel JJ. Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular risk. American Heart Journal 2022, 250: 11-22. PMID: 35526569, PMCID: PMC9836743, DOI: 10.1016/j.ahj.2022.04.009.
- Pulmonary Hypertension in Adults with Congenital Heart DiseaseGoldstein S, Krasuski R. Pulmonary Hypertension in Adults with Congenital Heart Disease. Cardiology Clinics 2022, 40: 55-67. PMID: 34809917, DOI: 10.1016/j.ccl.2021.08.006.
- Impact of mechanical versus bioprosthetic heart valve on severe maternal morbidity during delivery hospitalizationsDenoble A, Federspiel J, Goldstein S, Grotegut C. Impact of mechanical versus bioprosthetic heart valve on severe maternal morbidity during delivery hospitalizations. American Journal Of Obstetrics And Gynecology 2022, 226: s469-s470. DOI: 10.1016/j.ajog.2021.11.778.
- Impact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizationsDenoble A, Goldstein S, Grotegut C, Federspiel J. Impact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizations. American Journal Of Obstetrics And Gynecology 2022, 226: s77. DOI: 10.1016/j.ajog.2021.11.146.
- Instituting a Curriculum for Cardio-Obstetrics Subspecialty Fellowship Training.Minhas AS, Goldstein SA, Vaught AJ, Lewey J, Ward C, Schulman SP, Michos ED. Instituting a Curriculum for Cardio-Obstetrics Subspecialty Fellowship Training. Methodist DeBakey Cardiovascular Journal 2022, 18: 14-23. PMID: 35734150, PMCID: PMC9165665, DOI: 10.14797/mdcvj.1101.
- Risk Factors and Outcomes Associated with Hypertensive Disorders of Pregnancy in Maternal Congenital Heart DiseaseGoldstein SA, Savu A, Islam S, Ward CC, Krasuski RA, Grotegut CA, Newby LK, Hornberger LK, Windram J, Kaul P. Risk factors and outcomes associated with hypertensive disorders of pregnancy in maternal congenital heart disease. JACC: Advances. 2022 Jun 1;1(2):100036.
- Peripartum Cardiomyopathy.Farrell AS, Kuller JA, Goldstein SA, Dotters-Katz SK. Peripartum Cardiomyopathy. Obstetrical & Gynecological Survey 2021, 76: 485-492. PMID: 34449851, DOI: 10.1097/OGX.0000000000000903.
- AGE AND LOCATION OF DEATH DIFFER IN ADULT PATIENTS WITH CONGENITAL HEART DISEASE COMPARED WITH THE GENERAL POPULATIONGoldstein S, Kumar P, Shahid I, Serfas J, Krasuski M, Khan M, Krasuski R. AGE AND LOCATION OF DEATH DIFFER IN ADULT PATIENTS WITH CONGENITAL HEART DISEASE COMPARED WITH THE GENERAL POPULATION. Journal Of The American College Of Cardiology 2021, 77: 489. DOI: 10.1016/s0735-1097(21)01848-9.
- RACIAL AND ETHNIC DISPARITIES IN LOCATION OF DEATH AMONG ADULT CONGENITAL HEART DISEASE PATIENTSSerfas J, Kumar P, Shahid I, Goldstein S, Krasuski M, Khan M, Krasuski R. RACIAL AND ETHNIC DISPARITIES IN LOCATION OF DEATH AMONG ADULT CONGENITAL HEART DISEASE PATIENTS. Journal Of The American College Of Cardiology 2021, 77: 484. DOI: 10.1016/s0735-1097(21)01843-x.
- IMPACT OF CARDIOVASCULAR COMORBIDITY ON CONGENITAL HEART DISEASE DEATHSPinsker B, Shahid I, Kumar P, Krasuski M, Goldstein S, Serfas J, Khan M, Krasuski R. IMPACT OF CARDIOVASCULAR COMORBIDITY ON CONGENITAL HEART DISEASE DEATHS. Journal Of The American College Of Cardiology 2021, 77: 507. DOI: 10.1016/s0735-1097(21)01866-0.
- Pregnancy in a woman with congenitally corrected transposition of the great arteriesGoldstein S, Sorenson L, Chapa J, Krasuski R. Pregnancy in a woman with congenitally corrected transposition of the great arteries. Cleveland Clinic Journal Of Medicine 2021, 88: 228-236. PMID: 33795247, DOI: 10.3949/ccjm.88a.20136.
- 734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancyDeNoble A, Federspiel J, Wein L, Goldstein S, Grotegut C. 734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancy. American Journal Of Obstetrics And Gynecology 2021, 224: s460-s461. DOI: 10.1016/j.ajog.2020.12.757.
- 532 Comparison of N-terminal pro-brain natriuretic peptide levels in healthy obese and non-obese pregnant womenDeNoble A, Moyett J, Goldstein S, Ward C, James A, Grotegut C. 532 Comparison of N-terminal pro-brain natriuretic peptide levels in healthy obese and non-obese pregnant women. American Journal Of Obstetrics And Gynecology 2021, 224: s337. DOI: 10.1016/j.ajog.2020.12.553.
- Neurologic complications of congenital heart disease in adults.Goldstein SA, Goldstein LB. Neurologic complications of congenital heart disease in adults. Handbook Of Clinical Neurology 2021, 177: 15-22. PMID: 33632433, DOI: 10.1016/B978-0-12-819814-8.00011-1.
- Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary RevascularizationGoldstein S, Li S, Lu D, Matsouaka R, Rymer J, Fonarow G, de Lemos J, Peterson E, Pokorney S, Wang T, Al-Khatib S. Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization. The American Journal Of Cardiology 2020, 138: 26-32. PMID: 33068540, DOI: 10.1016/j.amjcard.2020.09.056.
- Increased Risk of Aortic Dissection Associated With Pregnancy in Women With Turner Syndrome: A Systematic Review.Hynes JS, Kuller JA, Goldstein SA, Ward CC, Muasher SJ. Increased Risk of Aortic Dissection Associated With Pregnancy in Women With Turner Syndrome: A Systematic Review. Obstetrical & Gynecological Survey 2020, 75: 566-575. PMID: 32997149, DOI: 10.1097/OGX.0000000000000833.
- Sex differences in left ventricular electrical dyssynchrony and outcomes with cardiac resynchronization therapyFriedman D, Emerek K, Sørensen P, Zeitler E, Goldstein S, Al-Khatib S, Søgaard P, Graff C, Atwater B. Sex differences in left ventricular electrical dyssynchrony and outcomes with cardiac resynchronization therapy. Heart Rhythm O2 2020, 1: 243-249. PMID: 34113878, PMCID: PMC8183970, DOI: 10.1016/j.hroo.2020.07.004.
- Causes of Death and Cardiovascular Comorbidities in Adults With Congenital Heart DiseaseGoldstein S, D’Ottavio A, Spears T, Chiswell K, Hartman R, Krasuski R, Kemper A, Meyer R, Hoffman T, Walsh M, Sang C, Paolillo J, Li J. Causes of Death and Cardiovascular Comorbidities in Adults With Congenital Heart Disease. Journal Of The American Heart Association 2020, 9: e016400. PMID: 32654582, PMCID: PMC7660712, DOI: 10.1161/jaha.119.016400.
- IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) UTILIZATION AMONG OLDER PATIENTS WITH LOW EJECTION FRACTION FOLLOWING CORONARY REVASCULARIZATION FOR MYOCARDIAL INFARCTIONGoldstein S, Lu D, Matsouaka R, Wang T, Rymer J, Pokorney S, Al-Khatib S. IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) UTILIZATION AMONG OLDER PATIENTS WITH LOW EJECTION FRACTION FOLLOWING CORONARY REVASCULARIZATION FOR MYOCARDIAL INFARCTION. Journal Of The American College Of Cardiology 2020, 75: 379. DOI: 10.1016/s0735-1097(20)31006-8.
- Future research prioritization in cardiac resynchronization therapyFudim M, Dalgaard F, Al-Khatib SM, J Friedman D, Lallinger K, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Schaber DE, Tang A, Ali-Ahmed F, Goldstein SA, Kaufman B, Fortman R, Davis JK, Inoue LYT, Sanders GD. Future research prioritization in cardiac resynchronization therapy. American Heart Journal 2020, 223: 48-58. PMID: 32163753, PMCID: PMC8667052, DOI: 10.1016/j.ahj.2020.02.011.
- Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDEZeitler E, Friedman D, Loring Z, Campbell K, Goldstein S, Wegermann Z, Schutz J, Smith N, Black-Maier E, Al-Khatib S, Piccini J. Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE. Heart Rhythm 2019, 17: 447-454. PMID: 31561032, PMCID: PMC7519585, DOI: 10.1016/j.hrthm.2019.09.024.
- Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)Goldstein S, Green J, Huber K, Wojdyla D, Lopes R, Alexander J, Vinereanu D, Wallentin L, Granger C, Al-Khatib S. Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial). The American Journal Of Cardiology 2019, 124: 1406-1412. PMID: 31474328, PMCID: PMC7194994, DOI: 10.1016/j.amjcard.2019.07.046.
- Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomesGoldstein S, Mentz R, Hellkamp A, Randolph T, Fonarow G, Hernandez A, Yancy C, Al‐Khatib S. Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes. Clinical Cardiology 2018, 42: 256-263. PMID: 30548280, PMCID: PMC6386168, DOI: 10.1002/clc.23135.
- Evaluation and Management of Maternal Congenital Heart Disease: A Review.Hopkins MK, Goldstein SA, Ward CC, Kuller JA. Evaluation and Management of Maternal Congenital Heart Disease: A Review. Obstetrical & Gynecological Survey 2018, 73: 116-124. PMID: 29480926, DOI: 10.1097/OGX.0000000000000536.
- The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia SyndromesGoldstein S, Ward C, Al-Khatib S. The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes. Journal Of Innovations In Cardiac Rhythm Management 2017, 9: 2996-3005. PMID: 32494470, PMCID: PMC7252881, DOI: 10.19102/icrm.2018.090103.
- Congenital and Acquired Valvular Heart Disease in PregnancyGoldstein S, Ward C. Congenital and Acquired Valvular Heart Disease in Pregnancy. Current Cardiology Reports 2017, 19: 96. PMID: 28840470, DOI: 10.1007/s11886-017-0910-6.
- Relationship Between Peak Troponin Values and Long‐Term Ischemic Events Among Medically Managed Patients With Acute Coronary SyndromesGoldstein S, Newby L, Cyr D, Neely M, Lüscher T, Brown E, White H, Ohman E, Roe M, Hamm C. Relationship Between Peak Troponin Values and Long‐Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes. Journal Of The American Heart Association 2017, 6: e005334. PMID: 28400368, PMCID: PMC5533023, DOI: 10.1161/jaha.116.005334.
- Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non–ST-Segment–Elevation Acute Coronary Syndromes Clinical TrialsKragholm K, Goldstein S, Yang Q, Lopes R, Schulte P, Bernacki G, White H, Mahaffey K, Giugliano R, Armstrong P, Harrington R, Tricoci P, Van de Werf F, Alexander J, Alexander K, Newby L. Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non–ST-Segment–Elevation Acute Coronary Syndromes Clinical Trials. Circulation 2016, 133: 1560-1573. PMID: 26957532, PMCID: PMC4856566, DOI: 10.1161/circulationaha.115.017299.
- Acute Coronary SyndromeFanaroff A, Rymer J, Goldstein S. Acute Coronary Syndrome. JAMA 2015, 314: 1990-1990. PMID: 26547478, DOI: 10.1001/jama.2015.12743.
- Does This Patient With Chest Pain Have Acute Coronary Syndrome?: The Rational Clinical Examination Systematic ReviewFanaroff A, Rymer J, Goldstein S, Simel D, Newby L. Does This Patient With Chest Pain Have Acute Coronary Syndrome?: The Rational Clinical Examination Systematic Review. JAMA 2015, 314: 1955-1965. PMID: 26547467, DOI: 10.1001/jama.2015.12735.